Literature DB >> 6552151

In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.

N Markowitz, D J Pohlod, L D Saravolatz, E L Quinn.   

Abstract

Since 1980, infections caused by methicillin-resistant (MR) Staphylococcus aureus have been epidemic among Detroit-area parenteral drug abusers. Because of the increasing importance of this pathogen, in vitro susceptibilities were compared for 39 isolates of MR S. aureus from 1980 to 1981, and for 56 strains of methicillin-susceptible (MS) S. aureus from 1972 to 1981, recovered from drug abusers with community-acquired infections. Agar dilution studies were performed at 35 degrees C, and minimal inhibitory concentrations were determined after incubation for 18 and 48 h. MR S. aureus exhibited cross-resistance to other beta-lactam antibiotics which frequently required 48 h for expression. MR S. aureus isolates were also resistant to tetracycline, clindamycin, tobramycin, and amikacin. All MR S. aureus isolates investigated synthesized an aminoglycoside 4'-nucleotidyltransferase. Emergence of resistance to cefotaxime, tetracycline, and clindamycin was noted among current MS S. aureus isolates. Vancomycin, fusidic acid, trimethoprim/sulfamethoxazole, and rifampin were the most active agents against MR S. aureus and were equally effective against MS S. aureus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6552151      PMCID: PMC184668          DOI: 10.1128/AAC.23.3.450

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.

Authors:  R SUTHERLAND; G N ROLINSON
Journal:  J Bacteriol       Date:  1964-04       Impact factor: 3.490

3.  A SURVEY OF METHICILLIN RESISTANCE IN STAPHYLOCOCCUS AUREUS.

Authors:  M T PARKER; M P JEVONS
Journal:  Postgrad Med J       Date:  1964-12       Impact factor: 2.401

4.  [Staphylococcus strains naturally resistant to methicillin and 5-methyl-3-phenyl-4-iso-oxazolyl-penicillin].

Authors:  Y A CHABBERT; J G BAUDENS
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-08

5.  A screening test for the detection of methicillin-resistant staphylococci.

Authors:  G M Churcher
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

6.  Determination of methicillin resistance of Staphylococcus aureus. Heterogeneity and its influence on the disc diffusion method.

Authors:  H O Hallander; G Laurell; K Dornbusch
Journal:  Scand J Infect Dis       Date:  1969

7.  In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.

Authors:  R L Thompson; K A Fisher; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

8.  Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus.

Authors:  J Klastersky; J Beumer; D Daneau
Journal:  Appl Microbiol       Date:  1971-12

9.  Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.

Authors:  D P Levine; R D Cushing; J Jui; W J Brown
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

10.  In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

View more
  15 in total

1.  Failure of routine susceptibility tests to detect imipenem resistance among strains of methicillin-resistant Staphylococcus aureus.

Authors:  J M Boyce; E Papa; R Dickenson; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

3.  Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents.

Authors:  C Watanakunakorn
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

4.  Activity of 18 antimicrobial agents against multi-resistant strains of Staphylococcus aureus isolated from intensive care patients.

Authors:  D Duncker; U Ullmann
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

Review 5.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

6.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus.

Authors:  B A Forbes; K D McClatchey; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

9.  Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.

Authors:  F Parras; M C Guerrero; E Bouza; M J Blázquez; S Moreno; M C Menarguez; E Cercenado
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C.

Authors:  W D Welch; P M Southern
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.